Plexus (NASDAQ:PLXS) Upgraded at Wall Street Zen

Key Points

• Analysts at Wall Street Zen upgraded Plexus Corporation from a "buy" rating to a "strong-buy" rating, indicating increased confidence in the stock's performance.
• Plexus reported earnings of $1.90 per share for the last quarter, exceeding analyst expectations of $1.71, with a revenue of $1.02 billion.
• Insiders, including CFO Patrick John Jermain and CEO Todd P. Kelsey, sold shares last month, indicating a decrease in their ownership in the company.

Plexus (NASDAQ:PLXS - Get Free Report) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating in a note issued to investors on Saturday.

Several other equities research analysts have also recently issued reports on PLXS. Stifel Nicolaus set a $140.00 target price on shares of Plexus in a report on Thursday, July 24th. Benchmark raised their target price on shares of Plexus from $160.00 to $165.00 and gave the stock a "buy" rating in a report on Monday, September 22nd. Weiss Ratings restated a "hold (c+)" rating on shares of Plexus in a report on Wednesday. Needham & Company LLC dropped their target price on shares of Plexus from $162.00 to $158.00 and set a "buy" rating on the stock in a report on Thursday, July 24th. Finally, Sidoti upgraded shares of Plexus from a "neutral" rating to a "buy" rating and raised their target price for the stock from $135.00 to $150.00 in a report on Friday, July 25th. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $155.60.

Plexus Trading Down 9.2%

NASDAQ:PLXS opened at $133.69 on Friday. The company's 50 day moving average price is $137.81 and its 200-day moving average price is $132.17. Plexus has a 52 week low of $103.43 and a 52 week high of $172.89. The company has a quick ratio of 0.74, a current ratio of 1.58 and a debt-to-equity ratio of 0.06. The stock has a market cap of $3.61 billion, a price-to-earnings ratio of 22.78 and a beta of 0.80.

Plexus (NASDAQ:PLXS - Get Free Report) last issued its earnings results on Wednesday, July 23rd. The technology company reported $1.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.19. Plexus had a net margin of 4.04% and a return on equity of 12.33%. The company had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $1.02 billion. During the same quarter last year, the company posted $1.45 earnings per share. The firm's quarterly revenue was up 6.0% on a year-over-year basis. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. On average, equities research analysts forecast that Plexus will post 5.9 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Plexus news, CFO Patrick John Jermain sold 2,500 shares of the stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $137.71, for a total value of $344,275.00. Following the transaction, the chief financial officer directly owned 20,959 shares in the company, valued at approximately $2,886,263.89. This trade represents a 10.66% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Todd P. Kelsey sold 1,500 shares of the stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $143.70, for a total transaction of $215,550.00. Following the completion of the transaction, the chief executive officer owned 69,214 shares in the company, valued at $9,946,051.80. The trade was a 2.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,856 shares of company stock valued at $2,142,440. 1.76% of the stock is currently owned by corporate insiders.

Institutional Trading of Plexus

Several institutional investors and hedge funds have recently modified their holdings of PLXS. Huntington National Bank raised its position in shares of Plexus by 41.5% during the 2nd quarter. Huntington National Bank now owns 324 shares of the technology company's stock valued at $44,000 after purchasing an additional 95 shares during the period. TD Private Client Wealth LLC raised its position in shares of Plexus by 185.6% during the 1st quarter. TD Private Client Wealth LLC now owns 514 shares of the technology company's stock valued at $66,000 after purchasing an additional 334 shares during the period. Banque Transatlantique SA bought a new stake in shares of Plexus during the 1st quarter valued at $71,000. CWM LLC raised its position in shares of Plexus by 65.7% during the 2nd quarter. CWM LLC now owns 537 shares of the technology company's stock valued at $73,000 after purchasing an additional 213 shares during the period. Finally, EverSource Wealth Advisors LLC raised its position in shares of Plexus by 583.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company's stock valued at $78,000 after purchasing an additional 490 shares during the period. 94.45% of the stock is currently owned by institutional investors.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.